Funders · Entity Annotation Prototype (beta)

1articles mentioning funders

1funder mentions

1distinct funders extracted

0%of mentions human-reviewed

Active filtersEntity: Astellas Pharma Inc. ×

Astellas Pharma Inc.

This funder is selected. Its supporting articles are shown below.

Astellas Pharma Inc.1

Articles mentioning Astellas Pharma Inc.

1 articles · page 1 of 1

520 Safety and tolerability of ASP1012, an oncolytic virus, in adults with locally advanced or metastatic solid tumors: Results from a first-in-human, phase 1, open-label, dose-escalation study

jitc · abstract · 2025-11-04 · 1 matching annotations

79.0%

Astellas Pharma Inc.ASP1012 la/m solid tumors advanced solid tumors Oxford PharmaGenesis Inc.

…uding 3×10 9 pfu/dose.Acknowledgements This study was funded by Astellas Pharma Inc. Medical writing support, conducted in accordance with Good Publ…

Browse funders

Astellas Pharma Inc.

Articles mentioning Astellas Pharma Inc.

520 Safety and tolerability of ASP1012, an oncolytic virus, in adults with locally advanced or metastatic solid tumors: Results from a first-in-human, phase 1, open-label, dose-escalation study